Vitamin D Intake Is Inadequate in Spinal Muscular Atrophy Type I Cohort: Correlations With Bone Health

被引:7
|
作者
Aton, Jennifer [1 ]
Davis, Rebecca Hurst [2 ]
Jordan, Kristine C. [3 ]
Scott, Charles B. [4 ]
Swoboda, Kathryn J. [2 ]
机构
[1] Intermt Healthcare, Murray, UT USA
[2] Univ Utah, Dept Neurol, Pediat Motor Disorders Res Program, Salt Lake City, UT 84132 USA
[3] Univ Utah, Div Nutr, Salt Lake City, UT 84132 USA
[4] CBS Squared Inc, Ft Washington, PA USA
关键词
vitamin D; spinal muscular atrophy type I; bone mineral density; SMN1; X-RAY ABSORPTIOMETRY; MINERAL DENSITY; POSTMENOPAUSAL WOMEN; BODY-COMPOSITION; NATURAL-HISTORY; CLASSIFICATION; CHILDREN; ADOLESCENTS; CHILDHOOD; IDENTIFICATION;
D O I
10.1177/0883073812471857
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Children with type I spinal muscular atrophy commonly demonstrate reduced bone mineral density. Our objectives were to evaluate and assess adequacy of vitamin D intake, serum levels, and association with bone mineral density. Assessments were completed using 3-day food records and dual energy x-ray absorptiometry scans. The spinal muscular atrophy type I cohort included 22 males and 18 females (N = 40), with a mean age of 18.6 months. Data collection occurred from 2001 to 2011. Seventy-five percent of patients had inadequate intake of vitamin D at the initial visit. Using mixed-effects analyses, vitamin D and calcium intakes correlated positively with bone mineral density (r = 0.31 and r = 0.53, respectively). Increased vitamin D and calcium consumption were associated with an increase in bone mineral density (P = .04 and P = .01, respectively). Vitamin D intake correlated positively with serum levels (r = 0.65). Further study is needed to determine optimal intakes of vitamin D and calcium in the spinal muscular atrophy type I population.
引用
收藏
页码:374 / 380
页数:7
相关论文
共 50 条
  • [1] BONE HEALTH AND GROWTH IN SPINAL MUSCULAR ATROPHY TYPE 2 AND 3
    Kipoglu, Osman
    Ozturan, Esin Karakilic
    Coskun, Orhan
    Ozturk, Ayse Pinar
    Yildiz, Edibe Pembegul
    Bas, Firdevs
    Aydinli, Nur
    CaliSkan, Mine
    [J]. JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2022,
  • [2] BONE HEALTH AND GROWTH IN SPINAL MUSCULAR ATROPHY TYPE 2 AND 3
    Kipoglu, Osman
    Karakilic Ozturan, Esin
    Coskun, Orhan
    Ozturk, Ayse Pinar
    Pembegul Yildiz, Edibe
    Bas, Firdevs
    Aydinli, Nur
    Caliskan, Mine
    [J]. JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2022, 85 (01): : 22 - 28
  • [3] Spinal muscular atrophy-type I
    Hardart, MKM
    Truog, RD
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2003, 88 (10) : 848 - 850
  • [4] Neonatal spinal muscular atrophy type I with bone fractures and heart defect
    Vaidla, Eve
    Talvik, Inga
    Kulla, Andres
    Sibul, Hijar
    Maasalu, Katre
    Metsvaht, Tuuh
    Piirsoo, Andres
    Talvik, Tiina
    [J]. JOURNAL OF CHILD NEUROLOGY, 2007, 22 (01) : 67 - 70
  • [5] Developmental milestones in type I spinal muscular atrophy
    De Sanctis, Roberto
    Coratti, Giorgia
    Pasternak, Amy
    Montes, Jacqueline
    Pane, Marika
    Mazzone, Elena S.
    Young, Sally Dunaway
    Salazar, Rachel
    Quigley, Janet
    Pera, Maria C.
    Antonaci, Laura
    Lapenta, Leonardo
    Glanzman, Allan M.
    Tiziano, Danilo
    Muntoni, Francesco
    Darras, Basil T.
    De Vivo, Darryl C.
    Finkel, Richard
    Mercuri, Eugenio
    [J]. NEUROMUSCULAR DISORDERS, 2016, 26 (11) : 754 - 759
  • [6] Drug treatment for spinal muscular atrophy type I
    Wadman, Renske I.
    Bosboom, Wendy M. J.
    van der Pol, W. Ludo
    van den Berg, Leonard H.
    Wokke, John H. J.
    Iannaccone, Susan T.
    Vrancken, Alexander F. J. E.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (04):
  • [7] Drug treatment for spinal muscular atrophy type I
    Bosboom, Wendy M. J.
    Vrancken, Alexander F. J. E.
    van den Berg, Leonard H.
    Wokke, John H. J.
    Iannaccone, Susan T.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01):
  • [8] Spectrum of Neuropathophysiology in Spinal Muscular Atrophy Type I
    Harding, Brian N.
    Kariya, Shingo
    Monani, Umrao R.
    Chung, Wendy K.
    Benton, Maryjane
    Yum, Sabrina W.
    Tennekoon, Gihan
    Finkel, Richard S.
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2015, 74 (01): : 15 - 24
  • [9] Drug treatment for spinal muscular atrophy type I
    Wadman, Renske I.
    Bosboom, Wendy M. J.
    van den Berg, Leonard H.
    Wokke, John H. J.
    Iannaccone, Susan T.
    Vrancken, Alexander F. J. E.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [10] Drug treatment for spinal muscular atrophy type I
    Wadman, Renske I.
    van der Pol, W. Ludo
    Bosboom, Wendy M. J.
    Asselman, Fay-Lynn
    van den Berg, Leonard H.
    Iannaccone, Susan T.
    Vrancken, Alexander F. J. E.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (12):